280 related articles for article (PubMed ID: 26987032)
1. Metformin inhibits prostate cancer cell proliferation, migration, and tumor growth through upregulation of PEDF expression.
Chen X; Li C; He T; Mao J; Li C; Lyu J; Meng QH
Cancer Biol Ther; 2016 May; 17(5):507-14. PubMed ID: 26987032
[TBL] [Abstract][Full Text] [Related]
2. Proapoptotic PEDF functional peptides inhibit prostate tumor growth--a mechanistic study.
Gong Q; Qiu S; Li S; Ma Y; Chen M; Yao Y; Che D; Feng J; Cai W; Ma J; Yang X; Gao G; Yang Z
Biochem Pharmacol; 2014 Dec; 92(3):425-37. PubMed ID: 25261795
[TBL] [Abstract][Full Text] [Related]
3. Pigment epithelium-derived factor inhibits lung cancer migration and invasion by upregulating exosomal thrombospondin 1.
Huang WT; Chong IW; Chen HL; Li CY; Hsieh CC; Kuo HF; Chang CY; Chen YH; Liu YP; Lu CY; Liu YR; Liu PL
Cancer Lett; 2019 Feb; 442():287-298. PubMed ID: 30439539
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits expression and secretion of PEDF in adipocyte and hepatocyte via promoting AMPK phosphorylation.
Yang S; Lv Q; Luo T; Liu L; Gao R; Chen S; Ye P; Cheng Q; Li Q
Mediators Inflamm; 2013; 2013():429207. PubMed ID: 24288442
[TBL] [Abstract][Full Text] [Related]
5. PEDF inhibits IL8 production in prostate cancer cells through PEDF receptor/phospholipase A2 and regulation of NFκB and PPARγ.
Hirsch J; Johnson CL; Nelius T; Kennedy R; Riese Wd; Filleur S
Cytokine; 2011 Aug; 55(2):202-10. PubMed ID: 21570865
[TBL] [Abstract][Full Text] [Related]
6. Pigment Epithelium-Derived Factor and its Phosphomimetic Mutant Induce JNK-Dependent Apoptosis and P38-Mediated Migration Arrest.
Konson A; Pradeep S; D'Acunto CW; Seger R
Cell Physiol Biochem; 2018; 49(2):512-529. PubMed ID: 30157491
[TBL] [Abstract][Full Text] [Related]
7. Vacuolar H+-ATPase is down-regulated by the angiogenesis-inhibitory pigment epithelium-derived factor in metastatic prostate cancer cells.
Sennoune SR; Bermudez LE; Lees JC; Hirsch J; Filleur S; Martínez-Zaguilán R
Cell Mol Biol (Noisy-le-grand); 2014 May; 60(1):45-52. PubMed ID: 24857383
[TBL] [Abstract][Full Text] [Related]
8. Positive correlation between PEDF expression levels and macrophage density in the human prostate.
Nelius T; Samathanam C; Martinez-Marin D; Gaines N; Stevens J; Hickson J; de Riese W; Filleur S
Prostate; 2013 Apr; 73(5):549-61. PubMed ID: 23038613
[TBL] [Abstract][Full Text] [Related]
9. Human adipose-derived mesenchymal stromal cell pigment epithelium-derived factor cytotherapy modifies genetic and epigenetic profiles of prostate cancer cells.
Zolochevska O; Shearer J; Ellis J; Fokina V; Shah F; Gimble JM; Figueiredo ML
Cytotherapy; 2014 Mar; 16(3):346-56. PubMed ID: 24424267
[TBL] [Abstract][Full Text] [Related]
10. Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation.
Nakamura K; Yamagishi S; Matsui T; Yoshida T; Takenaka K; Jinnouchi Y; Yoshida Y; Ueda S; Adachi H; Imaizumi T
Am J Pathol; 2007 Jun; 170(6):2159-70. PubMed ID: 17525281
[TBL] [Abstract][Full Text] [Related]
11. Pigment epithelium-derived factor (PEDF) inhibits breast cancer metastasis by down-regulating fibronectin.
Hong H; Zhou T; Fang S; Jia M; Xu Z; Dai Z; Li C; Li S; Li L; Zhang T; Qi W; Bardeesi AS; Yang Z; Cai W; Yang X; Gao G
Breast Cancer Res Treat; 2014 Nov; 148(1):61-72. PubMed ID: 25284724
[TBL] [Abstract][Full Text] [Related]
12. Pigment epithelium-derived factor inhibits the growth of human esophageal squamous cell carcinoma by suppressing neovascularization.
Kadoya M; Tamoto E; Shichinohe T; Hirano S
Hokkaido Igaku Zasshi; 2015 May; 90(1):17-29. PubMed ID: 26118299
[TBL] [Abstract][Full Text] [Related]
13. cDNA microarray analysis of pigment epithelium-derived factor-regulated gene expression profile in prostate carcinoma cells.
Liu W; Wu Z; Guan M; Lu Y
Int J Urol; 2009 Mar; 16(3):323-8. PubMed ID: 19207613
[TBL] [Abstract][Full Text] [Related]
14. Pigment epithelial-derived factor and melanoma differentiation associated gene-7 cytokine gene therapies delivered by adipose-derived stromal/mesenchymal stem cells are effective in reducing prostate cancer cell growth.
Zolochevska O; Yu G; Gimble JM; Figueiredo ML
Stem Cells Dev; 2012 May; 21(7):1112-23. PubMed ID: 21671747
[TBL] [Abstract][Full Text] [Related]
15. Cabazitaxel regimens inhibit the growth of prostate cancer cells and enhances the anti-tumor properties of PEDF with various efficacy and toxicity.
Jarvis C; Nelius T; Martinez-Marin D; Sennoune SR; Filleur S
Prostate; 2018 Sep; 78(12):905-914. PubMed ID: 29749077
[TBL] [Abstract][Full Text] [Related]
16. PEDF increases the tumoricidal activity of macrophages towards prostate cancer cells in vitro.
Martinez-Marin D; Jarvis C; Nelius T; de Riese W; Volpert OV; Filleur S
PLoS One; 2017; 12(4):e0174968. PubMed ID: 28403150
[TBL] [Abstract][Full Text] [Related]
17. Pigment epithelial-derived factor inhibits c-FLIP expression and assists ciglitazone-induced apoptosis in hepatocellular carcinoma.
Lai LJ; Ho TC
Anticancer Res; 2011 Apr; 31(4):1173-80. PubMed ID: 21508362
[TBL] [Abstract][Full Text] [Related]
18. The molecular impact of pigment epithelium-derived factor, PEDF, on lung cancer cells and the clinical significance.
Chen J; Ye L; Zhang L; Jiang WG
Int J Oncol; 2009 Jul; 35(1):159-66. PubMed ID: 19513563
[TBL] [Abstract][Full Text] [Related]
19. Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor (PEDF) RNA ratio in vitro and in a murine ocular melanoma model.
Yang H; Xu Z; Iuvone PM; Grossniklaus HE
Mol Vis; 2006 May; 12():511-7. PubMed ID: 16735992
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of pigment epithelium-derived factor for neoadjuvant radiation therapy in patients with locally advanced rectal carcinoma.
Yi H; Ji D; Zhan T; Yao Y; Li M; Jia J; Li Z; Gu J
Int J Oncol; 2016 Oct; 49(4):1415-26. PubMed ID: 27431441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
